Tumor metastasis: Mechanistic insights and therapeutic interventions.

Tumor metastasis: Mechanistic insights and therapeutic interventions.
复制标题

肿瘤转移:机制见解和治疗干预

DOI:
10.1002/mco2.100
复制
发表时间:
2021-12
期刊:
影响因子:
9.9
通讯作者:
Zhang X
Zhang X
中科院分区:
其他
文献类型:
--
作者:
Liu M;Yang J;Xu B;Zhang X

文献摘要

参考文献

被引文献

相似文献

Cancer metastasis is responsible for the vast majority of cancer‐related deaths worldwide. In contrast to numerous discoveries that reveal the detailed mechanisms leading to the formation of the primary tumor, the biological underpinnings of the metastatic disease remain poorly understood. Cancer metastasis is a complex process in which cancer cells escape from the primary tumor, settle, and grow at other parts of the body. Epithelial‐mesenchymal transition and anoikis resistance of tumor cells are the main forces to promote metastasis, and multiple components in the tumor microenvironment and their complicated crosstalk with cancer cells are closely involved in distant metastasis. In addition to the three cornerstones of tumor treatment, surgery, chemotherapy, and radiotherapy, novel treatment approaches including targeted therapy and immunotherapy have been established in patients with metastatic cancer. Although the cancer survival rate has been greatly improved over the years, it is still far from satisfactory. In this review, we provided an overview of the metastasis process, summarized the cellular and molecular mechanisms involved in the dissemination and distant metastasis of cancer cells, and reviewed the important advances in interventions for cancer metastasis. Cancer metastasis is a complex process in which cancer cells escape from the primary tumor, settle and grow at other parts of the body. A variety of stromal cells, immune cells and other molecular components surrounding the tumor provide signals that enhance the metastatic potential of cancer cells. With the deepening understanding of mechanisms of tumorigenesis and metastasis in recent years, a plethora of treatment approaches have been established in patients with metastatic cancer.
DOI: 10.1038/ncb3250
发表时间: 2015-11
影响因子: 21.3
作者:
Alanko J;Mai A;Jacquemet G;Schauer K;Kaukonen R;Saari M;Goud B;Ivaska J
通讯作者: Ivaska J
DOI: 10.1016/j.tcb.2020.07.003
发表时间: 2020-10
影响因子: 19
作者:
Bakir B;Chiarella AM;Pitarresi JR;Rustgi AK
通讯作者: Rustgi AK
DOI: 10.1126/science.aao4227
发表时间: 2018-09-28
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Albrengues J;Shields MA;Ng D;Park CG;Ambrico A;Poindexter ME;Upadhyay P;Uyeminami DL;Pommier A;Küttner V;Bružas E;Maiorino L;Bautista C;Carmona EM;Gimotty PA;Fearon DT;Chang K;Lyons SK;Pinkerton KE;Trotman LC;Goldberg MS;Yeh JT;Egeblad M
通讯作者: Egeblad M
DOI: 10.1016/j.ccell.2018.02.008
发表时间: 2018-03-12
期刊: Cancer cell
影响因子: 50.3
作者:
Allen AE;Locasale JW
通讯作者: Locasale JW
miR-128-3p 同时过度激活 Wnt/β-catenin 和 TGF beta 信号传导导致 NSCLC 中化疗耐药相关的转移
DOI: 10.1038/ncomms15870
发表时间: 2017-06-19
影响因子: 16.6
作者:
Cai J;Fang L;Huang Y;Li R;Xu X;Hu Z;Zhang L;Yang Y;Zhu X;Zhang H;Wu J;Huang Y;Li J;Zeng M;Song E;He Y;Zhang L;Li M
通讯作者: Li M